Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: A randomized, controlled trial

Circulation: Cardiovascular Interventions

Volumn 4, Issue 5, 2011, Pages 456-462

  Maioli, Mauro ^a   Toso, Anna ^a   Leoncini, Mario ^a   Micheletti, Carlo ^a   Bellandi, Francesco ^a  

^a MISERICORDIA E DOLCE HOSPITAL   (Italy)

Author keywords

Acute kidney injury; Acute myocardial infarction; Catheter based coronary intervention; Contrast media

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BICARBONATE; CLOPIDOGREL; CREATININE; HEPARIN; IODIXANOL; ISOTONIC SOLUTION;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HIGH RISK PATIENT; HUMAN; HYDRATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE KIDNEY INJURY; AGED; ANGIOPLASTY; CLINICAL PROTOCOLS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; FLUID THERAPY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SODIUM BICARBONATE; SODIUM CHLORIDE;

EID: 82955229555     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.111.961391     Document Type: Article

References (29)

1. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1418-1428.
2. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259-2264. (Pubitemid 34535335)
3. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol. 2004;44:1763-1771. (Pubitemid 39424073)
4. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006;113:1799-1806. (Pubitemid 43958473)
5. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, Fahy M, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108:2769-2775. (Pubitemid 37498979)
6. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780-1785. (Pubitemid 39424075)
7. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354:2773-2782. (Pubitemid 43974195)
8. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast-associated nephropathy. Arch Intern Med. 2002;162:329-336.
9. Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA, Tumlin J. CIN Consensus Working Panel: Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006;98:59K-77K.
10. Nikolsky E, Mehran R. Hydration protocols to reduce the incidence of contrast-induced nephropathy. J Invasive Cardiol. 2008;20:527-538.
11. Zagler A, Azadpour M, Mercado C, Hennekens CH. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J. 2006;151:140-145. (Pubitemid 41815344)
12. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284-294. (Pubitemid 351665489)
13. Spargias K, Alexopoulos E, Kyrzopoulos S, Iacovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004;110:2837-2842. (Pubitemid 39473606)
14. McCullough PA, Bertrand ME, Brinker JA, Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol. 2006;48:692-699. (Pubitemid 44175706)
15. From AM, Al Badarin FJ, McDonald FS, Bartholmai BJ, Cha SS, Rihal CS. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials. Circ Cardiovasc Interv. 2010;3:351-358.
16. Reed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. J Am Coll Cardiol Cardiovasc Interv. 2009;2:645-654.
17. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuck GJ, Bersin RM, Moore AV, Simonton CA III, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate. JAMA. 2004;291:2328-2334. (Pubitemid 38656299)
18. Thomsen HS. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media. Eur J Radiol. 2006;60:307-313.
19. TIMI Study Group. Definitions used in TIMI trials. http://www.timi.org. Accessed May 3, 2006.
20. National Kidney Foundation. K/DOQJ. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl 1):51-237.
21. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol. 2004;44:1393-1399. (Pubitemid 39303939)
22. Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, Cohen HA, Holmes DR. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50:584-590. (Pubitemid 47199002)
23. Brar SS, Hiremath S, Dangas G, Mehran R, Brar SK, Leon MB. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4: 1584-1592.
24. Hoste EA, De Waele JJ, Gevaert SA, Uchino S, Kellum JA. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant. 2010;25:747-758.
25. Zoungas S, Ninomiya T, Huxley R, Cass A, Jardine M, Gallagher M, Patel A, Vasheghani-Farahani A, Sadigh G, Perkovic V. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med. 2009;151:631-638.
26. Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F. Sodium bicarbonate versus saline for the prevention of contrastinduced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol. 2008;52:599-604.
27. Brar SS, Shen AY, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, Ree M, Shah AI, Burchette RJ. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA. 2008;300:1038-1046.
28. Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol. 2007;100:781-786. (Pubitemid 47268267)
29. Recio-Mayoral A, Chaparro M, Prado B, Cozar R, Mendez I, Banerjee D, Kaski JC, Cubero J, Cruz JM. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention. The RENO study. J Am Coll Cardiol. 2007;49:1283-1288. (Pubitemid 46467227)